NMNancy Mohammad

Nancy Mohammad

*This is an algorithmically generated author record based on publicly available information.

Nancy Mohammad has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • THE RELATIONSHIP BETWEEN HIGH SENSITIVE C- REACTIVE PROTEIN,INTERLEUKIN-6 , TUMOR NECROSIS FACTORS -α AND COGNITIVE FUNCTION IN ELDERLY DIABETICS IN ZAGAZIG UNIVERSITY HOSPITALS

    by Amira Ahmed Mahmoud, Nancy Mohammad, Ahmad Sallam Soliman

    Many reaserches have shown associations between inflammatory markers and the risk of cognitive functions decline. Higher serum levels of CRP,IL-6 and TNF-α are associated with deteriorating cognitive function in elderly. The goal of this reaserch was to detect cognitive impairment in elderly individuals with diabetes and their relation to hs-CRP,IL-6 and TNF-α in those individuals. Two hundred fifty-five elderly individuals which were divided into 3 groups according to present or absence of diabetes together with level of diabetes control; Group I: 85 elderly individuals without diabetes, Group II: 85 elderly patients with controlled diabetes. Group III: 85 elderly patients with uncontrolled diabetes. Routine laboratory investigations together with lipid profile , hs- CRP,IL-6 and TNF-α were analyzed in three groups using blood serum sample then correlated to degree of cognitive impairment using mini mental state examination (MMSE). The present study proved that a statistical significant negative correlation between hs-CRP and MMS score examination in total population was found , there is statistical significant negative correlation between hs-CRP ,IL-6 ,TNF-α and MMS score examination in total elderly subjects with diabetes.. As well, there is significant positive correlation between hs-CRP and parameters of diabetic control So, estimation of inflammatory markers in elderly patients with diabetes may be a reliable indicator to identify and anticipate cognitive dysfunction in such individuals.KEYWORDS: hs-CRP,IL-6, TNF-α , cognitive function, elderly diabetics


  • Open Access

    Newly Diagnosed Diabetes in Patients with COVID-19: Different Types and Short-Term Outcomes

    by Alaa A. Farag, Hassan M. Hassanin, Hanan H. Soliman, Ahmad Sallam, Amany M. Sediq, Elsayed S. Abd Elbaser, Khaled Elbanna

    A great global concern is currently focused on the coronavirus disease 2019 (COVID-19) pandemic and its associated morbidities. The goal of this study was to determine the frequency of newly diagnosed diabetes mellitus (DM) and its different types among COVID-19 patients, and to check the glycemic control in diabetic cases for three months. After excluding known cases of DM, 570 patients with confirmed COVID-19 were studied. All participants were classified as non-diabetic or newly discovered diabetic. According to hemoglobin A1c (HbA1c) and fasting insulin, newly discovered diabetic patients were further classified into pre-existing DM, new-onset type 1 DM, and new-onset type 2 DM. Glycemic control was monitored for three months in newly diagnosed diabetic patients. DM was diagnosed in 77 patients (13.5%); 12 (2.1%) with pre-existing DM, 7 (1.2%) with new-onset type 1 DM, and 58 (10.2%) with new-onset type 2 DM. Significantly higher rates of severe infection and mortality (p < 0.001 and p = 0.046) were evident among diabetic patients. Among survived diabetic patients (n = 63), hyperglycemia and the need for anti-diabetic treatment persisted in 73% of them for three months. COVID-19 was associated with a new-onset of DM in 11.4% of all participants and expression of pre-existing DM in 2.1% of all participants, both being associated with severe infection. COVID-19 patients with newly diagnosed diabetes had high risk of mortality. New-onset DM persisted for at least three months in more than two-thirds of cases.